All Forward Pharma articles
-
BusinessBiogen pays $1.25bn to protect multiple sclerosis drug sales
Agreement with Forward Pharma gives Biogen license to keep selling blockbuster Tecfidera
Agreement with Forward Pharma gives Biogen license to keep selling blockbuster Tecfidera